Search
Development of a vectorized RNA-based nanomedicine as novel therapy for Alzheimer’s Disease – siRNAlz
The siRNAlz project aims to develop a siRNA-based nanomedicine that can be used to regulate a specific genetic risk factor involved in the pathobiology of Alzheimer’s disease (AD). The achievement of effective RNA-based therapies for AD relies on the development of cutting-edge nanotechnologies with
Identification of innovative NHEJ inhibitors – NEJIN
Most anti-cancer treatments aim at generating burst of DNA double strand breaks (DSBs), the most toxic DNA lesion. Several drawbacks are associated with these therapies: (i) their inherent toxicity, (ii) the relapse when the cancer stem cell is not shattered, and (iii) the emergence of resistance to
Towards a smart blood culture bottle: Machine learning assisted electrochemical profiling to provide early in-situ identification of bloodstream infection pathogens – E-MOC
Despite all improvements in the diagnosis of infectious diseases in the last 20 years, the socioeconomic burden of bloodstream infections (BSI) is still high for every country all around the world. Approximately 20% of global mortality worldwide (11 million deaths per year) is related to sepsis. Thu
Selective ACSL4 inhibitors to interrogate ferroptosis in Parkinson disease – FerInh4Park
Ferroptosis, first coined in 2012, is a regulated cell death (RCD) characterized by iron-dependent accumulation of lipid hydroperoxides associated with an insufficient capacity to eliminate these oxidation products. This RCD has significant implications in diverse pathologies, including Parkinson an
Targeting a new signaling cascade with specific inhibitors for obesity treatment – GreatObTreat
Obesity is the most serious public health problem in recent decades. It is associated with multiple comorbidities, such as type 2 diabetes or myocardial infarction. Treatment options remain quite limited: on the one hand, surgical interventions with good weight loss results, but with significant and
New Class Of mUlti-taRgeted Antibody druG conjugatEs – COURAGE
Cancer still constitutes major public health around the world. Developing new treatments belonging to the class of targeted therapies, such as therapeutic antibodies (Abs), is highly recommended to improve cancer patients' care. However, the overall clinical efficacy of naked antibodies remains limi
Asthmakine– Small molecule IL-4/IL-13 protein-protein interaction inhibitors for asthma – Asthmakine
IL-4 and IL-13 play key roles in the pathogenesis of asthma and are appealing therapeutic targets for the treatment of asthma. These cytokines interact with a common partner, IL-4Ra, within two types of activated trimers and can thus be modulated simultaneously. Dupilumab, a human monoclonal antibod
Pro-ligand conjugated to antibodies for improved treatment of cancers – PROLIGAND
Immunotherapy is applied to many tumors to inhibit the growth of cancer cells using recombinant antibodies directed against specific targets. Therapeutic efficacy may depend on antibody binding to inhibit target activity and/or stimulation of the main immune response pathways. Recently, the three pa
Engineering a bacterial secretion platform for rapid, high-yield, low-cost production of peptides and proteins for diagnosis and biomedicine – BactCellFactory
Recombinant protein production is a multi-billion euro market with critical applications for industy and medicine. Various methods of production are available using cellular organisms of all domains of life. Yet, most rely on expensive, and time-consuming steps performed in dedicated facilities to o
Bioinspired polyhydroxamic sequestering agents for the in vivo decorporation of actinides – ActiDecorp
ActiDecorp is an interdisciplinary French-German project gathering organic, coordination and radiochemists, nuclear toxicologists, physiologists, and pharmacists from 4 complementary teams willing to design decorporating agents able to treat accidental poisoning by actinides (An = U/Np(VI), Np/Pu(IV
Carbohydrate cOnjugates as Trojan horsE to improve Antibiotic iMport – CO-TEAM
The increase of antimicrobial resistance is a major threat for individual and public health. Consequently, new weapons to fight the emerging multidrug-resistant bacteria are quickly required. The ESKAPE pathogens are at the frontline of these problematic life-threatening drug resistant nosocomial pa
Development and evaluation of Spheroplexes as oral mRNA vaccine able to cross gastro-intestinal barriers and induce mucosal immune response – SpherOrVac
Mucosal tissues are composed by a specialized epithelium covered by a mucus layer, and are the main portal of entry of most of pathogens. The induction of local (mucosal) immune response is highly desirable in order to effectively prevent mucosal infection and transmission, especially against rapidl
The therapeutic effect of platelet-rich plasma on neuropathic pain – PRPain
Chronic pain not only causes physical suffering but also affects daily life, leading to symptoms such as irritability, aggression, withdrawal, and loss of autonomy. Additionally, it increases the risk of developing mood disorders. Therefore, managing chronic pain is a significant public health chall
Evaluation of a novel targeted fusion-enhanced oncolytic virotherapy platform in a canine translational clinical trial – OVICAN
Anti-tumour virotherapy represents a promising alternative to conventional anti-cancer treatments. Oncolytic viruses (OV) infect tumour cells more efficiently than healthy cells, leading to tumour destruction via direct lysis and/or induction of an anti-tumour immune response. Work in our laboratory
Investigation of the physiological effects of Lipiodol® to improve couples'infertility – LIPIOFERT
Lipiodol® is a contrast product developed by Guerbet and used in particular to assess tubal patency in the context of female infertility. Several studies have shown that its use increases the chances of pregnancy in the following months. The objective of this project, presented by an academic team w
A new approach to intranasal vaccination. – NOSIMMUNE
The primary goal of this research project is to build and evaluate a new vaccinal protein vector optimized for intranasal vaccination against respiratory infections. This new, bi-functional vector is purposed:
Development of Efflux Pump Inhibitors for overcoming innate and acquired AntiMicrobial Resistance in Enterobacterale infections – EPI-4-AMR
Drug resistant Enterobacterale are a major threat to global healthcare, and it has become clear in the last years that new tools are urgently needed to combat these bacteria. In the endeavour to develop new antibiotics against these Gram-negative bacteria, a major hurdle is the bacterial expression
Clostidioides difficile polysaccharides as therapeutic targets – PSDIFF
Clostridioides difficile, an anaerobic Gram-positive spore-forming bacterium, is responsible for a wide spectrum of infections ranging from diarrhea to life-threatening pseudomembranous colitis. The use of antibiotic therapy raises concerns about the selection of antibiotic-resistant bacteria at hos
Magnetoplasmonic nanoflowers for image-guided treatment of atherosclerosis – nanoHyMPI
Atherosclerosis is a chronic systemic inflammatory disease affecting the large and medium-sized arteries. The main danger of atherosclerosis lies in the rupture of the plaques which leads to severe complications (heart attacks, stroke). Although treatments which rest on the drug delivery are daily i
Orally-active Biomimetic-polymers TArgeting C. difficile – OBTAC
Clostridioides difficile (C. difficile) is a toxigenic bacterium responsible for severe nosocomial intestinal infections. About 500.000 patients are infected every year in the USA, causing 13.000 deaths, according to the American CDC. To treat such intestinal infections, only 2 antibiotics are recom
Added value of the extracellular matrix in solid tumors: how to target the matrisome for therapy – TheraMatrix
The study of solid tumor development and metastatic progression has mainly focused on biochemical signals regulating downstream signaling pathways. The power of the extracellular compartment, and especially the non-cellular fraction, has only recently been appreciated as a potential supply for pro-
Proof of Concept of a Local PROteoLIposomes-based Therapy Against Acute Lungs Infection in Chronic Granulomatous Disease Patients – PROLIC
Chronic Granulomatous Disease(CGD) is a rare genetic disease of innate immunodeficiency affecting phagocytes (neutrophils, macrophages) of patients by dysfunction of the membrane NADPH oxidase complex. This enzyme is responsible for the production of microbicidal toxic oxygen derivatives (ROS). The
Investigating post-transcriptional regulation of BCL11A to develop therapeutic approaches to ß-hemoglobinopathies – PREDA
Beta-hemoglobinopathies are genetic anemias caused by a reduced or abnormal synthesis of the adult hemoglobin beta-chain. The clinical severity is alleviated by the persistent production of the fetal beta-like gamma-globin chain in adulthood. BCL11A is the major fetal gamma-globin transcriptional re
New antimicrobial molecules targeting trans-translation – NAMM3T
The main goal of this project is to use an integrative approach to develop novel antimicrobial molecules targeting ribosomal trans-translation in multi-resistant pathogenic bacteria. Trans-translation is performed by the hybrid transfer-messenger RNA (tmRNA) and its protein partner SmpB. Given the a
Lung Epithelium Targeting of RNA for COPD Treatment – LUNETA
Patients with chronic obstructive pulmonary disease (COPD) suffer from chronic lung inflammation, tissue remodeling and persistent airflow limitation. Although corticosteroids and bonchodilatators can reduce the mortality risk, they still marginally improve lung function. There is an urgent need to
Nanoparticle-based thermal, mechanical and electrical treatment alleviating desmoplasia and improving the therapy of deep-seated tumors – JoulMECT
The overall 5-year survival for pancreatic and hepatic cancer patients has not evolved much over the past decades, indicating that current therapeutic approaches are often inefficient. Poor therapeutic outcomes are due to the impenetrability of the tumor mass to drugs. The tumor is protected by a de
New antimicrobials against ESKAPE pathogens to fight nitric oxide stress resistance – NO-ESKAPE
Antibiotic resistance is a dramatic health challenge and development of new antibiotics efficient against Gram-negative bacteria of the ESKAPE group is an emergency. In this project, we propose the development of effective first-in-class antibiotics to tackle bacterial resistance by acting on a nove
Capsid Like Particles as Vaccine Vectors – CALIPSO
The constant need for immunization to prevent life-threatening diseases worldwide is urging the search for new vaccines. Progress in the development of modular virus-like particles for antigen (Ag) delivery is currently impaired by difficulties in the grafting of large Ag. We recently established a
Calculation of intracranial and spinal compliance by imaging and modeling coupling. – CALCOCIMO
Cerebral vascular and cerebrospinal fluid (CSF) oscillations are at the origin of the intracranial pressure (ICP). The compliance of the craniospinal system dampens the systolic vascular expansion, which is vital for good brain perfusion. However, the measurement of this compliance is not accessible
A rapid and non-invasive approach to assess tuberculosis treatment efficacy in real-time in patients : toward a personalized medicine – TB-in-time
Tuberculosis (TB) caused by Mycobacterium tuberculosis (Mtb) complex remains one of the most prevalent deadly infectious diseases worldwide. TB treatments are long, and patients’ adherence is hampered by frequent side effects, entailing premature treatment arrest and exposing to disease relapse. To
TARGETING THE CO-INHIBITORY RECEPTOR G6B IN THROMBOSIS AND THROMBOCYTOPENIA – TARGITT
Platelet activation must be tightly regulated to allow a rapid response to vascular injury and invading pathogens, whilst preventing excessive bleeding and thrombosis. Central to these responses are the structurally-distinct immunoreceptor tyrosine-based activation motif (ITAM)-containing receptors
Collagen targeted thermotherapy of kidney fibrosis – NanoKFT
Fibrosis is defined as an excessive accumulation of extracellular matrix (ECM) components such as certain collagens, and is the leading cause of morbidity and mortality in chronic diseases. Major efforts have focused on preventing ECM synthesis, but these have been unsuccessful and conceptually unsu
Engineering Tryptophan Metabolism to treat chronic inflammatory diseases – TrypENGINE
Chronic inflammatory diseases, including inflammatory bowel diseases (IBD) and rheumatoid arthritis (RA) are immune-related disorders characterized by inappropriate inflammation. Their incidence has increased dramatically in Western countries in recent decades, supporting a role for environmental fa
Development of a “nose-to-brain” theranostic formulation of nanobodies for Alzheimer ‘s disease. – NoToBAlz
The overall aim of the NoToBAlz project is to develop an innovative theranostic approach, gathering a new nanobody-based strategy (i.e. small functional fragments of heavy chain antibodies), a straightforward route of administration (i.e. nose to brain) and an adapted molecules delivery system (i.e
Light-induced skin extracellular matrix remodelling through ROS generation: highlighting the potential of sublethal-photodynamic therapy – LUMOS
Impairment in extracellular matrix (ECM) regulation is involved in cancers and fibrosis and therefore represents a promising therapeutic target. Our aim is to focus on the positive effects that reactive oxygen species (ROS) exert on ECM remodeling. Indeed, in LUMOS project we propose an innovative s
Carbon Dots for siRNA delivery and PDT: Application to atopic dermatitis – CaDoRNA
Atopic dermatitis (AD) is a common inflammatory skin disease, often of early-life onset, for which the prevalence continues to increase in industrialized countries, affecting approximately 15-30% of children and 2-10% of adult. AD remains challenging to treat, therefore the CadoRNA project is design
Extracellular Vesicles for Aerosol DElivery applied to Cystic Fibrosis – EVADE
Mutations in the gene encoding the CFTR protein affect mucus-producing epithelia, including the lungs and gastrointestinal tract. In the lungs, viscous mucus obstructs the bronchi, creating an environment conducive to chronic bacterial infection, which leads to the destruction of the lung parenchyma
Targeting the 2C protein of enteroviruses to develop broad-spectrum antivirals derived from Fluoxetine – Fluox2C
Enteroviruses (EVs) are pathogens of increasing public health concern with recurrent emerging agents. Although many EVs are associated with mild clinical manifestations, they can lead to serious complications such as encephalitis, meningitis, pneumonia, myocarditis and poliomyelitis. Given the large
Bile Salt Hydrolases (BSHs) – based biotherapies to fight giardiasis – BileBaG
Giardiasis is a widespread intestinal parasitic disease caused by the protozoan Giardia intestinalis. This digestive parasitosis is considered a neglected disease by the World Health Organization (WHO). Giardiasis is very common, affecting children in particular, and can go unnoticed in some patient
Proof of concept of new potential Therapeutic drugs to treat PreEclampsia – TheraPE
Preeclampsia (PE) is a hypertensive disorder of pregnancy related to a placentation defect. PE is a major cause of maternal and perinatal morbidity and mortality worldwide. Moreover, women who had PE and adults born preterm are at increased risk of cardiovascular diseases which are the leading cause
Non-viral genome editing of retinal dystrophies – PolyCas9_RD
Genome editing mediated by CRISPR-Cas9 has shown great promise for the treatment of retinal dystrophies (RD). Currently, adeno-associated viruses are the most widely used vectors for retinal gene therapies but their small packaging capacity and permanent transgene expression makes them suboptimal fo
Advanced liver-on-chip model coupled to system biology and mathematical model to track Non-Alcoholic Fatty Liver Disease – Track-NAFLD
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in western countries. It can be dichotomically divided into steatosis, associated with a benign outcome, and steatohepatitis (NASH), characterized by progression to fibrosis, hepatocellular carcinoma and increased mor
Inhibiting Quorum Sensing to fight P. aeruginosa/S. aureus biofilms in cystic fibrosis – TARGET-QS
Antimicrobial resistance (AMR) is a public health threat causing 1.2 million deaths worldwide every year. In particular, the ability of bacteria to form biofilms makes them more resistant to antibiotic treatments, which constitutes a major medical challenge. TARGET-QS is a multidisciplinary project
Organometallic-Containing Triazoles Against Resistant FungI – OTARI
The OTARI project aims to understand how organometallic-containing azoles are able to escape resistance in fungi and to use this knowledge to develop better antifungal agents. The project leaders have recently shown that known antifungal agents containing a triazole structure, such as fluconazole (F
A new pharmacological opportunity in acute myocardial infarction by preventing activation of the translation initiation factor eIF5A – MOMI
Myocardial infarction, which is involved in 20% of deaths in Europe, corresponds to a blood flow arrest (= ischemia) that deprives the heart of its vital oxygen and nutrient requirements, the deleterious effects of which are time dependent. This is followed, spontaneously or after medical interventi
Evaluate the therapeutic potential of the elimination of ACPA positive B cells to cure RA – ACPA4CURE
Restoring immune tolerance without inducing global immunosuppression using innovative antigen-specific therapeutic molecules is the main challenge of the Cure RA consortium (2018-2025), a collaborative project between 4 academic teams and the Arthritis R&D Company. As a proof of concept, we have dem
Surrogate chaperons to extend the half-life of therapeutic factor VIII – nanoF8
Hemophilia A is a rare X-linked bleeding disorder that results from insufficient levels of procoagulant factor VIII. Replacement therapy using exogenous factor VIII remains the most efficient strategy to prevent or treat bleeds. It is however limited by the short half-life of factor VIII, that impos
CFTR stabilizers: validation of novel therapeutic tools in cystic fibrosis – STABTHER
Cystic fibrosis (CF) is the most common lethal autosomal recessive genetic disease in Caucasian populations. Partial or total loss-of-function of the CFTR chloride channel causes mucus thickness and accumulation in the respiratory and digestive tracts. In lungs, the cycles of infection and inflammat
Immunotherapy resistance in kidney cancer: Understanding, educating and predicting – Combo-to-fight-RCC
Clear cell Renal Cell Carcinoma (RCC) represents 85% of kidney cancers and 3% of adult cancers. The majority of RCCs present an inactivation of the VHL gene inducing the constitutive stabilization of HIF-1/2 transcription factors and leading to the overexpression the pro-inflammatory cytokines like
Diagnostic biosensors and in vivo bioluminescence imaging model for Alzheimer’s disease – SENS-AD
Despite significant progress made towards understanding the pathophysiology of Alzheimer’s disease, only few efficient treatments are currently available. Early diagnosis for this disease is also a challenge. This project aims to investigate the phenomenon that are known to occur before the cognitiv
Fight nosocomial Infections with Cu-based Salts (FICuS) – FICuS
Bacterial pathogens causing Nosocomial Infections (NIs) pose increasing challenges to hospitals due to their increasing resistance to antibiotics. Metallic surfaces and fabrics in physical contact with infected patients are contaminated. Bacteria can proliferate on these substrates increasing the ri
Designing Inhibitors of Phosphopantetheinyl Transferases Of Pathogenic bacteria – DIPTOP
Many mycobacteria are human pathogens: Mycobacterium tuberculosis (Mtb), the etiological agent of tuberculosis, caused nearly 1.6 million deaths in 2021, and Mycobacterium abscessus (Mab) induces lung infections in patients with cystic fibrosis or weakened defences. Treatments exist but they are lon